FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2064039263> ?p ?o ?g. }

• W2064039263 endingPage "446" @default.
• W2064039263 startingPage "439" @default.
• W2064039263 abstract "Impaired cognition, fatigue, and diminished quality of life (QOL) are commonly associated with breast cancer chemotherapy. This randomized, double-blind, placebo-controlled pilot trial assessed the feasibility of quantifying the effects of epoetin alfa on cognitive function and mood, and evaluated its effects on fatigue and QOL in patients with breast cancer treated with anthracycline-based adjuvant or neoadjuvant chemotherapy. Patients were randomized to receive epoetin alfa 40,000 U subcutaneously once weekly or placebo at the beginning of 4 cycles of chemotherapy administered over 12 weeks. Cognitive function was assessed by Executive Interview (EXIT25) and Clock Drawing Tasks; mood by Profile of Mood States; anemiarelated symptoms, including fatigue, by the Functional Assessment of Cancer Therapy—Anemia (FACT-An) subscale; and QOL by Linear Analog Scale Assessment. Ninety-four patients were evaluable for efficacy and safety. Mean change in EXIT25 scores from baseline to cycle 4 in the epoetin alfa group was —1.3 ± 3.3; the mean change was 0.3 ± 2.4 in the placebo group (a negative change indicates improved executive function). There was no difference between groups in mean change in EXIT25 score from baseline to 6-month follow-up assessment. Mean hemoglobin levels were higher in the epoetin alfa group compared with the placebo group after 4 cycles of chemotherapy. Epoetin alfa recipients had less of a decrease in FACT-An subscale scores from baseline to cycle 4 and improvement in FACT-An subscale scores at 6- month follow-up assessment compared with placebo. Epoetin alfa therapy was well tolerated. These data suggest that epoetin alfa may have attenuated the cognitive impairment and fatigue that occurred during adjuvant breast cancer chemotherapy." @default.
• W2064039263 created "2016-06-24" @default.
• W2064039263 creator A5008682252 @default.
• W2064039263 creator A5020890676 @default.
• W2064039263 creator A5029647491 @default.
• W2064039263 creator A5030497065 @default.
• W2064039263 creator A5046653516 @default.
• W2064039263 creator A5059365988 @default.
• W2064039263 creator A5071432873 @default.
• W2064039263 creator A5080900202 @default.
• W2064039263 date "2005-02-01" @default.
• W2064039263 modified "2023-10-17" @default.
• W2064039263 title "Feasibility of Quantifying the Effects of Epoetin Alfa Therapy on Cognitive Function in Women with Breast Cancer Undergoing Adjuvant or Neoadjuvant Chemotherapy" @default.
• W2064039263 cites W1789804267 @default.
• W2064039263 cites W1821554592 @default.
• W2064039263 cites W1847137107 @default.
• W2064039263 cites W1867073577 @default.
• W2064039263 cites W1884165293 @default.
• W2064039263 cites W1885881044 @default.
• W2064039263 cites W1977238326 @default.
• W2064039263 cites W1995479486 @default.
• W2064039263 cites W1998600728 @default.
• W2064039263 cites W2008606533 @default.
• W2064039263 cites W2034987918 @default.
• W2064039263 cites W2044390583 @default.
• W2064039263 cites W2051884508 @default.
• W2064039263 cites W2063931484 @default.
• W2064039263 cites W2085943860 @default.
• W2064039263 cites W2092669968 @default.
• W2064039263 cites W2098757634 @default.
• W2064039263 cites W2101364791 @default.
• W2064039263 cites W2103730697 @default.
• W2064039263 cites W2104239228 @default.
• W2064039263 cites W2106431827 @default.
• W2064039263 cites W2106716097 @default.
• W2064039263 cites W2122965222 @default.
• W2064039263 cites W2133244075 @default.
• W2064039263 cites W2139422964 @default.
• W2064039263 cites W2142463112 @default.
• W2064039263 cites W2143418376 @default.
• W2064039263 cites W2156098875 @default.
• W2064039263 cites W2267597394 @default.
• W2064039263 cites W2345834322 @default.
• W2064039263 cites W4249354118 @default.
• W2064039263 doi "https://doi.org/10.3816/cbc.2005.n.002" @default.
• W2064039263 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15748464" @default.
• W2064039263 hasPublicationYear "2005" @default.
• W2064039263 type Work @default.
• W2064039263 sameAs 2064039263 @default.
• W2064039263 citedByCount "103" @default.
• W2064039263 countsByYear W20640392632012 @default.
• W2064039263 countsByYear W20640392632013 @default.
• W2064039263 countsByYear W20640392632014 @default.
• W2064039263 countsByYear W20640392632015 @default.
• W2064039263 countsByYear W20640392632016 @default.
• W2064039263 countsByYear W20640392632017 @default.
• W2064039263 countsByYear W20640392632018 @default.
• W2064039263 countsByYear W20640392632019 @default.
• W2064039263 countsByYear W20640392632020 @default.
• W2064039263 countsByYear W20640392632021 @default.
• W2064039263 countsByYear W20640392632022 @default.
• W2064039263 countsByYear W20640392632023 @default.
• W2064039263 crossrefType "journal-article" @default.
• W2064039263 hasAuthorship W2064039263A5008682252 @default.
• W2064039263 hasAuthorship W2064039263A5020890676 @default.
• W2064039263 hasAuthorship W2064039263A5029647491 @default.
• W2064039263 hasAuthorship W2064039263A5030497065 @default.
• W2064039263 hasAuthorship W2064039263A5046653516 @default.
• W2064039263 hasAuthorship W2064039263A5059365988 @default.
• W2064039263 hasAuthorship W2064039263A5071432873 @default.
• W2064039263 hasAuthorship W2064039263A5080900202 @default.
• W2064039263 hasConcept C118552586 @default.
• W2064039263 hasConcept C121608353 @default.
• W2064039263 hasConcept C126322002 @default.
• W2064039263 hasConcept C142724271 @default.
• W2064039263 hasConcept C143998085 @default.
• W2064039263 hasConcept C159110408 @default.
• W2064039263 hasConcept C168563851 @default.
• W2064039263 hasConcept C1862650 @default.
• W2064039263 hasConcept C204787440 @default.
• W2064039263 hasConcept C27081682 @default.
• W2064039263 hasConcept C2776164570 @default.
• W2064039263 hasConcept C2776694085 @default.
• W2064039263 hasConcept C2778248108 @default.
• W2064039263 hasConcept C2779951463 @default.
• W2064039263 hasConcept C2780733359 @default.
• W2064039263 hasConcept C530470458 @default.
• W2064039263 hasConcept C71924100 @default.
• W2064039263 hasConceptScore W2064039263C118552586 @default.
• W2064039263 hasConceptScore W2064039263C121608353 @default.
• W2064039263 hasConceptScore W2064039263C126322002 @default.
• W2064039263 hasConceptScore W2064039263C142724271 @default.
• W2064039263 hasConceptScore W2064039263C143998085 @default.
• W2064039263 hasConceptScore W2064039263C159110408 @default.
• W2064039263 hasConceptScore W2064039263C168563851 @default.
• W2064039263 hasConceptScore W2064039263C1862650 @default.
• W2064039263 hasConceptScore W2064039263C204787440 @default.
• W2064039263 hasConceptScore W2064039263C27081682 @default.

• next